Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Intuitive Surgical Community
NasdaqGS:ISRG Community
5
Narratives
written by author
20
Comments
on narratives written by author
340
Fair Values set
on narratives written by author
Community Investing Ideas
Intuitive Surgical
Popular
Undervalued
Overvalued
Intuitive Surgical
UN
Unike
Community Contributor
Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth
Catalysts Most Immediate Catalysts (1–2 Years) Increased Adoption of Robotic Surgery: Hospitals and surgical centers continue to adopt Intuitive Surgical’s da Vinci systems as clinical evidence shows improved outcomes and reduced recovery times. Expansion into more surgical specialties (e.g., gynecology, urology, general surgery) drives near-term revenue growth.
View narrative
US$325.55
FV
47.5% overvalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
19
users have followed this narrative
5 months ago
author updated this narrative
Intuitive Surgical
TO
Tokyo
Community Contributor
From Battle Field to Robotic Surgery
Intuitive Surgical (ISRG) is a pioneer in robotic-assisted surgery, revolutionizing the medical field with its da Vinci surgical system. Founded in 1995, the company has continuously innovated, making minimally invasive surgery more precise and efficient.
View narrative
US$400.91
FV
19.8% overvalued
intrinsic discount
12.02%
Revenue growth p.a.
Set Fair Value
9
users have liked this narrative
13
users have commented on this narrative
44
users have followed this narrative
4 months ago
author updated this narrative
Intuitive Surgical
AN
AnalystLowTarget
Consensus Narrative from 27 Analysts
Global Healthcare Cost Pressures And Tariffs Will Depress Margins
Key Takeaways Heightened pricing pressures, regulatory scrutiny, and strengthening competition threaten to erode margins and limit long-term revenue and earnings growth. Shifting demographics, industry consolidation, and preference for alternative surgical options will likely reduce demand for robotic systems and challenge market expansion.
View narrative
US$447.47
FV
7.3% overvalued
intrinsic discount
12.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
about 1 month ago
author updated this narrative
Intuitive Surgical
AN
AnalystHighTarget
Consensus Narrative from 27 Analysts
Da Vinci 5 Rollout Will Leverage Aging And Digital Trends
Key Takeaways Accelerated adoption of da Vinci 5 and digital ecosystem could drive earlier-than-expected system upgrades, higher margins, and strong recurring revenue streams. Expansion into new markets and specialties, supported by manufacturing scale-up, positions the company for outsized, sustainable long-term growth.
View narrative
US$675.00
FV
28.9% undervalued
intrinsic discount
18.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
about 1 month ago
author updated this narrative
Intuitive Surgical
AN
AnalystConsensusTarget
Consensus Narrative from 27 Analysts
Emerging Markets Will Expand Robotic-Assisted Surgery Adoption
Key Takeaways Expanding global adoption and procedure diversity, coupled with innovative products and digital tools, are fueling recurring revenues, margin stability, and long-term competitive advantage. Increasing regulatory and payer support, driven by strong clinical outcomes, is reducing adoption barriers and supporting durable growth across multiple healthcare markets.
View narrative
US$583.64
FV
17.7% undervalued
intrinsic discount
13.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
5
users have commented on this narrative
148
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
ISRG
ISRG
Intuitive Surgical
Your Fair Value
US$
Current Price
US$480.26
16.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
16b
2015
2018
2021
2024
2025
2027
2030
Revenue US$16.2b
Earnings US$4.6b
Advanced
Set Fair Value